FOXA1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
Jingjing WeiHaiyang YuTan LiuZiming WangChuandong LangYue-Yin PanPublished in: Thoracic cancer (2023)
This study uncovered that FOXA1-induced LINC00621 promotes LUAD progression via the miR-34a-5p/TGFBR1/TGF-β axis, and is one novel therapeutic target that may be used in LUAD treatment.